The evolving landscape of drug legalization and use in the United States has created challenges for those pursuing a security clearance. While 23 states have legalized recreational marijuana and 38 allow medicinal use, federal policies remain stringent. Understanding these policies is crucial for clearance applicants and holders. Download our latest report on drugs and security clearance trends.
Marijuana and Security Clearance Policies
The Office of the Director of National Intelligence (ODNI) issued updated guidance in 2021 clarifying that past drug use shouldn’t be a permanent disqualifier for clearance applicants. However, agencies often advise abstinence for at least a year prior to application. Legislation like The Dismantling Outdated
Obstacles and Barriers to Individual Employment (DOOBIE) Act aims to reduce barriers related to marijuana use, but federal law still prohibits clearances for current drug users under the Bond Amendment.
The Future of Drug Policies
The Department of Justice’s proposal to reschedule marijuana as a Schedule III drug could signal changes in how medicinal marijuana is viewed federally. However, applicants and holders must remain cautious, as agency-specific policies may still impose stricter regulations.
Honesty and adherence to federal policies remain the cornerstones of maintaining eligibility for a security clearance. For breakdowns of current clearance cases appearing before DOHA, read the full report.
